Clinica Baviera (CBAV) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.146x

Based on the latest financial reports, Clinica Baviera (CBAV) has a cash flow conversion efficiency ratio of 0.146x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€14.17 Million ≈ $16.57 Million USD) by net assets (€97.36 Million ≈ $113.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Clinica Baviera market cap and net worth for the company's overall valuation and market capitalisation.

Clinica Baviera - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Clinica Baviera's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Clinica Baviera Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinica Baviera ranked by their cash flow conversion efficiency. Explore CBAV cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
G R Infraprojects Limited NSE:GRINFRA	0.043x
HIT Welding Industry Co. Ltd. SHE:301137	0.038x
Multi Bintang Indonesia Tbk JK:MLBI	0.329x
Beijing Fengshangshiji Culture Medi SHE:300860	0.015x
Sparekassen Sjaelland-Fyn A/S CO:SPKSJF	0.107x
Hang Xiao Steel Structure Co Ltd SHG:600477	0.025x
Corsair Gaming Inc NASDAQ:CRSR	0.045x
Greenworks (Jiangsu) Co. Ltd. A SHE:301260	N/A

Annual Cash Flow Conversion Efficiency for Clinica Baviera (2005–2024)

The table below shows the annual cash flow conversion efficiency of Clinica Baviera from 2005 to 2024. View Clinica Baviera stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€98.36 Million ≈ $114.99 Million	€62.76 Million ≈ $73.38 Million	0.638x	+1.85%
2023-12-31	€92.28 Million ≈ $107.88 Million	€57.81 Million ≈ $67.59 Million	0.627x	-19.75%
2022-12-31	€68.37 Million ≈ $79.93 Million	€53.38 Million ≈ $62.40 Million	0.781x	-7.70%
2021-12-31	€55.39 Million ≈ $64.76 Million	€46.86 Million ≈ $54.78 Million	0.846x	+20.75%
2020-12-31	€44.90 Million ≈ $52.50 Million	€31.46 Million ≈ $36.77 Million	0.700x	-15.05%
2019-12-31	€30.80 Million ≈ $36.01 Million	€25.40 Million ≈ $29.70 Million	0.825x	+41.07%
2018-12-31	€28.76 Million ≈ $33.63 Million	€16.81 Million ≈ $19.66 Million	0.585x	-8.14%
2017-12-31	€24.88 Million ≈ $29.09 Million	€15.83 Million ≈ $18.51 Million	0.636x	-12.74%
2016-12-31	€18.57 Million ≈ $21.72 Million	€13.55 Million ≈ $15.84 Million	0.729x	+43.39%
2015-12-31	€21.31 Million ≈ $24.92 Million	€10.84 Million ≈ $12.67 Million	0.509x	+6.31%
2014-12-31	€20.20 Million ≈ $23.62 Million	€9.66 Million ≈ $11.30 Million	0.478x	+18.62%
2013-12-31	€25.35 Million ≈ $29.63 Million	€10.22 Million ≈ $11.95 Million	0.403x	+4.02%
2012-12-31	€20.86 Million ≈ $24.38 Million	€8.09 Million ≈ $9.45 Million	0.388x	-36.41%
2011-12-31	€23.83 Million ≈ $27.86 Million	€14.53 Million ≈ $16.98 Million	0.610x	-5.44%
2010-12-31	€22.40 Million ≈ $26.19 Million	€14.45 Million ≈ $16.89 Million	0.645x	+65.96%
2009-12-31	€20.87 Million ≈ $24.39 Million	€8.11 Million ≈ $9.48 Million	0.388x	-27.99%
2008-12-31	€19.02 Million ≈ $22.24 Million	€10.26 Million ≈ $12.00 Million	0.539x	-45.12%
2007-12-31	€19.88 Million ≈ $23.24 Million	€19.54 Million ≈ $22.84 Million	0.983x	+21.61%
2006-12-31	€19.49 Million ≈ $22.79 Million	€15.75 Million ≈ $18.42 Million	0.808x	-11.07%
2005-12-31	€14.34 Million ≈ $16.76 Million	€13.03 Million ≈ $15.23 Million	0.909x	--

About Clinica Baviera

MC:CBAV Spain Diagnostics & Research

Market Cap

$1.07 Billion

€916.02 Million EUR

Market Cap Rank

#9808 Global

#70 in Spain

Share Price

€57.20

Change (1 day)

+1.42%

52-Week Range

€40.10 - €61.40

All Time High

€61.40